Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III PEG-Intron in HIV-infected Patients (Study P00738)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00035360
Recruitment Status : Completed
First Posted : May 6, 2002
Last Update Posted : March 10, 2017
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2003
Actual Study Completion Date : October 2003